Modelos celulares hepáticos para el estudio del metabolismo de los lípidos. Revisión de literatura
Liver cell models for studying lipid metabolism. Literature review
Palabras clave:
Hepatocitos, Triglicéridos, Ácido oleico (es)Hepatocytes, Triglycerides, Oleic Acid (en)
Introducción. El hígado juega un papel importante en la homeostasis lipídica, especialmente en la síntesis de ácidos grasos y triglicéridos. Una amplia variedad de modelos celulares ha sido utilizada para investigar el metabolismo lipídico hepático y para elucidar detalles específicos de los mecanismos bioquímicos del desarrollo y progresión de enfermedades relacionadas, brindando información para tratamientos que reduzcan su impacto. Los modelos celulares hepáticos poseen un alto potencial en la investigación del metabolismo de lípidos y de agentes farmacológicos o principios activos que permiten la reducción de la acumulación de lípidos.
Objetivo. Comparar algunos modelos celulares hepáticos utilizados para el estudio del metabolismo lipídico, sus características y los resultados más relevantes de investigación en ellos.
Materiales y métodos. Se realizó una búsqueda sistemática en bases de datos sobre los modelos celulares hepáticos de mayor uso para el estudio del metabolismo de lípidos.
Resultados. Se exponen los cinco modelos celulares más utilizados para este tipo de investigaciones, destacando su origen, aplicación, ventajas y desventajas al momento de estimular el metabolismo lipídico.
Conclusión. Para seleccionar el modelo celular, el investigador debe tener en cuenta cuáles son los requerimientos y el proceso que desea evidenciar, sin olvidar que los resultados obtenidos solo serán aproximaciones de lo que en realidad podría suceder a nivel del hígado como órgano.
Introduction: The liver plays an important role in lipid homeostasis, especially in the synthesis of fatty acids and triglycerides. A wide variety of cell models have been used to investigate liver lipid metabolism and to elucidate specific details of the biochemical mechanisms involved in the development and progression of related diseases, providing information for treatments that reduce their impact. Liver cell models have a high potential for the investigation of lipid metabolism, as well as pharmacological agents or active principles that allow the reduction of lipid accumulation.
Objective: To compare some liver cell models used for studying lipid metabolism, their characteristics and the most relevant research results.
Materials and methods: A systematic search of databases was performed on the most commonly used liver cell models for the study of lipid metabolism.
Results: The five most commonly used cell models for this type of research are presented in this paper, highlighting their origin, application, advantages and disadvantages when stimulating lipid metabolism.
Conclusion: In order to select a cell model, researchers should take into account the requirements and the process they wish to demonstrate, without forgetting that the results obtained will only be approximations of what could actually happen in the liver as an organ.
Descargas
Citas
Green CJ, Pramfalk C, Morten KJ, Hodson L. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. Am J Physiol Endocrinol Metab. 2015;308(1):E1-20. http://doi.org/f6sr24.
Samanez CH, Caron S, Briand O, Dehondt H, Duplan I, Kuipers F, et al. The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism. Arch Physiol Biochem. 2012;118(3):102-11. http://doi.org/cvgb.
Donato MT, Lahoz A, Castell J V, Gómez-Lechón MJ. Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab. 2008;9(1):1-11. http://doi.org/bbz53z.
Navarro V, Zabala A, Gómez S, Portillo M. Metabolismo del colesterol: Bases actualizadas. Rev Esp Obes. 2009;7(6):360-84.
Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008;9(2):125-38. http://doi.org/dntz3d.
Ros E. Doble inhibición del colesterol: papel de la regulación intestinal y hepática. Rev Esp Cardiol. 2006;6(Suppl G):52-62. http://doi.org/ckd5rc.
Lafontan M. Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways. Am J Physiol Cell Physiol. 2012;302(2):C327-59. http://doi.org/cw2m49.
Ikonen E. Mechanisms for Cellular Cholesterol Transport : Defects and Human Disease. Physiol Rev. 2006;86(4):1237-61. http://doi.org/b7cdmq.
Maldonado-Saavedra O, Ramirez-Sánchez I, García-Sánchez JR, Ceballos-Reyes GM, Mendez-Blaina E. Colesterol : Función biológica e implicaciones médicas. Rev Mex Cienc Farm. 2012;43(2):7-22.
Li AP. Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem Biol Interact. 2007;168(1):16-29. http://doi.org/cpvq9q.
Groneberg DA, Grosse-Siestrup C, Fischer A. In Vitro Models to Study Hepatotoxicity. Toxicol Pathol. 2002;30(3):394-9. http://doi.org/ds8bz4.
Green CJ, Johnson D, Amin HD, Sivathondan P, Silva MA, Wang LM, et al. Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line. Am J Physiol Endocrinol Metab. 2015;309(6): E511-22. http://doi.org/f7r8sb.
Cui W, Chen SL, Hu KQ. Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. Am J Transl Res. 2010;2(1):95-104.
Ferramosca A, Zara V. Modulation of hepatic steatosis by dietary fatty acids. World J Gastroenterol. 2014;20(7):1746-55. http://doi.org/f5thtj.
Guguen-Guillouzo C, Campion JP, Brissot P, Launois B, Bourel M, Guillouzo A. high yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver. Cell Biol Int Rep. 1982;6(6):625-8. http://doi.org/bcsghr.
Guguen-Guillouzo C, Guillouzo A. General Review on In Vitro Hepatocyte Models and Their Applications. In: Maurel P, editor. Hepatocytes: Methods in Molecular Biology. New York: Springer; 2010. p. 1-40. http://doi.org/fj2xh5.
Anthérieu S, Chesné C, Li R, Guguen-Guillouzo C, Guillouzo A. Optimization of the HepaRG cell model for drug metabolism and toxicity studies. Toxicol In Vitro. 2012;26(8):1278-85. http://doi.org/f4gwfw.
De Gottardi A, Vinciguerra M, Sgroi A, Moukil M, Ravier-Dall’Antonia F, Pazienza V, et al. Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes. Lab Investig. 2007;87(8):792-806. http://doi.org/bgcb2m.
Perttilä J, Huaman-Samanez C, Caron S, Tanhuanpää K, Staels B, Yki-Järvinen H, et al. PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis. Am J Physiol Endocrinol Metab. 2012;302(9): E1063-9. http://doi.org/f3xfhw.
Chávez-Tapia NC, Rosso N, Uribe M, Bojalil R, Tiribelli C. Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes. Ann Hepatol. 2014;13(1):113-20.
Meex SJ, Andreo U, Sparks JD, Fisher EA. Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion? J Lipid Res. 2011;52(1):152-8. http://doi.org/czqdx4.
Miyata S, Inoue J, Shimizu M, Sato R. Allyl isothiocyanate suppresses the proteolytic activation of sterol regulatory element-binding proteins and de novo fatty acid and cholesterol synthesis. Biosci Biotechnol Biochem. 2016;80(5):1006-11. http://doi.org/cvgc.
Shao F, Ford DA. Elaidic acid increases hepatic lipogenesis by mediating sterol regulatory element binding protein-1c activity in HuH-7 cells. Lipids. 2014;49(5):403-13. http://doi.org/f5447s.
Rohwedder A, Zhang Q, Rudge SA, Wakelam MJ. Lipid droplet formation in response to oleic acid in Huh-7 cells is mediated by the fatty acid receptor PPAR. J Cell Sci. 2014;127(Pt 14):3104-15. http://doi.org/f59zw3.
Arrol S, Mackness MI, Laing I, Durrington PN. Lipoprotein secretion by the human hepatoma cell line HepG2: differential rates of accumulation of apolipoprotein B and lipoprotein lipids in tissue culture media in response to albumin, glucose and oleate. Biochim Biophys Acta. 1991;1086(1):72-80. http://doi.org/b67jv8.
Gdula-Argasińska J, Garbacik A, Tyszka-Czochara M, Woźniakiewicz M, Paśko P, Czepiel J. Identification of lipid derivatives in HepG2 cells. Acta Biochim Pol. 2013;60(4):811-5.
Gómez-Lechón MJ, Donato MT, Martínez-Romero A, Jiménez N, Castell JV, O’Connor JE. A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact. 2007;165(2):106-16. http://doi.org/cb676j.
Forte TM. Primary hepatocytes in monolayer culture: a model for studies on lipoprotein metabolism. Ann Rev Physiol. 1984;46(31):403-15. http://doi.org/dc94rt.
Schippers IJ, Moshage H, Roelofsen H, Muller M, Heymans HSA, Ruiters M, et al. Immortalized human hepatocytes as a tool for the study of hepatocytic (de-)differentiation. Cell Biol Toxicol. 1997;13(4-5):375-86. http://doi.org/b8q6vb.
Castell JV, Jover R, Martínez-Jiménez CP, Gómez-Lechón MJ. Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opin Drug Metab Toxicol. 2006;2(2):183-212. http://doi.org/db5mq2.
Gómez-Lechón MJ, Donato T, Ponsoda X, Fabra R, Trullenque R, Castell JV. Isolation, Culture and Use of Human Hepatocytes in Drug Research. In: Castell JV, Gómez-Lechón MJ. In Vitro Methods in Pharmaceutical Research. London: Academic Press; 1996. 129-153. http://doi.org/frqwvv.
Gripon P, Rumin S, Urban S, Le-Seyec J, Glaise D, Cannie I, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A. 2002;99(24):15655-60. http://doi.org/fwfwn8.
Aninat C, Piton A, Glaise D, Le Charpentier T, Langouët S, Morel F, et al. Expression of Cytochrome P450, conjugating Enzymes and Nuclear Receptors in Human Hepatoma HepaRG Cells. Drug Metab Dispos. 2006;34(1):75-83. http://doi.org/cjzb3p.
Caron S, Verrijken A, Mertens I, Samanez CH, Mautino G, Haas JT, et al. Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia. Arterioscler Thromb Vasc Biol. 2011;31(3):513-9. http://doi.org/dmk25b.
Nolan CJ, Larter CZ. Lipotoxicity: Why do saturated fatty acids cause and monounsaturates protect against it? J Gastroenterol Hepatol. 2009;24(5):703-6. http://doi.org/dnb3w7.
Ricchi M, Odoardi MR, Carulli L, Anzivino C, Ballestri S, Pinetti A, et al. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J Gastroenterol Hepatol. 2009;24(5):830-40. http://doi.org/dh85dj.
Miyata S, Inoue J, Shimizu M, Sato R. 4’-Hydroxyflavanone suppresses activation of sterol regulatory element-binding proteins and de novo lipid synthesis. FEBS Lett. 2012;586(13):1778-82. http://doi.org/f33fr9.
Javitt NB. HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J. 1990;4(2):161-8. http://doi.org/cvgf.
Rowe C, Gerrard DT, Jenkins R, Berry A, Durkin K, Sundstrom L, et al. Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation. Hepatology. 2013;58(2):799-809. http://doi.org/f6dccn.
Fang DL, Wan Y, Shen W, Cao J, Sun ZX, Yu HH, et al. Endoplasmic reticulum stress leads to lipid accumulation through upregulation of SREBP-1c in normal hepatic and hepatoma cells. Mol Cell Biochem. 2013;381(1):127-37. http://doi.org/f5brn2.
Park JY, Kim Y, Im JA, Lee H. Oligonol suppresses lipid accumulation and improves insulin resistance in a palmitate-induced in HepG2 hepatocytes as a cellular steatosis model. BMC Complement Altern Med. 2015;15:185. http://doi.org/f7g7rh.
Gibbons GF, Khurana R, Odwell A, Seelaenderz MC. Lipid balance in HepG2 cells: active synthesis and impaired mobilization. J Lipid Res. 1994;35(10):1801-8.
Ellsworth JL, Erickson SK, Cooper AD. Very low and low density lipoprotein synthesis and secretion by the human hepatoma cell line HepG2: effects of free fatty acid. J Lipid Res. 1986;27(8):858-74.
Dashti N, Wolfbauer G. Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J Lipid Res. 1987;28(4):423-36. PMID: 3035039.
Gorgani-Firuzjaee S, Khatami S, Adeli K, Meshkani R. SH2 domain-containing inositol 5-phosphatase (SHIP2) regulates de-novo lipogenesis and secretion of apoB100 containing lipoproteins in HepG2 cells. Biochem Biophys Res Commun. 2015;464(4):1028-33. http://doi.org/cvgg.
Kamper M, Manns CC, Plieschnig JA, Schneider WJ, Ivessa NE, Hermann M. Estrogen enhances secretion of apolipoprotein B-100 containing lipoproteins by BeWo cells. Biochimie. 2015;112:121-8. http://doi.org/f7bjfn.
Tabboon P, Sripanidkulchai B, Sripanidkulchai K. Hypocholesterolemic mechanism of phenolics-enriched extract from Moringa oleifera leaves in HepG2 cell lines. Songklanakarin J Sci Technol. 2016;38(2):155-61. http://doi.org/cvgh.
Wu T, Zhong L, Hong Z, Li Y, Liu X, Pan L, et al. The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols. J Pharmacol Sci. 2015;127(3):251-9. http://doi.org/f69b7z.
Li B, Chen X, Wang Z, Liu H, Liu B, Yu S, et al. Two new monoterpenes and one dicaffeic acid ester from Sibiraea angustata with hypolipidemic activities in HepG2 cells in Vitro. Phytochemistry Letters. 2015;13:319-23. http://doi.org/cvgj.
Kang H. Olea europaea Linn (Oleaceae) Fruit Pulp Extract Suppresses Sterol Regulatory Element-Binding Proteins-1c via AMP-Activated Protein Kinase Activation in Human Hepatic Cells. Trop J Pharm Res. 2014;13(8):1265. http://doi.org/cvgk.
Tenore GC, Stiuso P, Campiglia P, Novellino E. In vitro hypoglycaemic and hypolipidemic potential of white tea polyphenols. Food Chem. 2013;141(3):2379-84. http://doi.org/f5b3f5.
Licencia
Derechos de autor 2019 Revista de la Facultad de Medicina

Esta obra está bajo una licencia Creative Commons Reconocimiento 3.0 Unported.
-